m m diameter, grow in pairs or chains in medium, catalase (-)
Lancefield groups
: distinguished by Lancefield (1933) based on Ag composition: A, B, C, D and G
Hemolysis
: b = clear zone surrounding colony on blood agar plate = full hemolysis
a
= green zone surrounding colony on blood agar plate = partial hemolysis
g
= no hemolysis
Streptococcus pyogenes
Basics: Group A,
b -hemolytic, fimbriae-like appendages, produce hyaluronic acid and hyaluronidase, form long chains
Charact
: facultative anaerobic, b hemolysis, sheep blood- inhibition of H. haemolyticus, killed by 30min at 60° C
Lab ID
: lancefield grouping, bacitracin test (95%), 1 hr office test- extraction of CHO- highly specific
Ag Structure
:
M protein
(more than 80 serotypes)
Extend from cell wall as fimbriae-like projections
N-terminus confers Ag variations
Homology between different M proteins
Ý near C-terminus
Tandem repeats within gene
Þ size variation
Others:
C polysaccharides: L-rhammose and N-acetyl glucosamine (2:1)
T-protein
M-associated protein (MAP): Ag similarity to components of myocardium
Serum opacity factor (SOF): is useful (as well as MAP) for typing Group A strep which is not M-typable
Extracellular Proteins
Streptolysin O
: lethal to most euk cells, causes memb damage via interaction with cholesterol and induces brisk antibody response after pharyngeal or systemic infection – less after skin infection
Ab response useful in diagnosing recent strep infection in patients suffering from acute rheumatic fever
Streptolysin S
: non-antigenic; responsible for surface hemolysis on blood agar plates; inhibited by phospholipids
Nucleases
: 4 Ag-distinct (A,B,C,D); play role in liquifaction of abscess; antibody to Dnase B Þ diagnose strep skin infection
Strep Pyrogenic Exotoxins (SPE)
: at least 3 serotypes: A,B,C (now up to J);
member of superantigen family: stimulates immune sysem in non-specific manner resulting in severe disease
Induces erythyma (type C acts on hypothalamus to produce fever); rash also seen in some patients
structural genes carried by bacteriophages
Pathogenicity
M protein
: anti-phagocytic by preventing deposition of C3b (type specific antibody neutralize this ability)
lipoteichoic acid
(cell wall): mediates adherence to buccal mucosal epithelial cells
any anti-microbial with gram-positive activity will be effective
Clindamycin
(should be added regimen): penetrates euk cells (lactams like penicillin do not), inhibits protein synth (and thus toxin production), eagle effect: effective against stationary phase of growth (which
ß efficacy of lactams)
Streptococcus agalactiae
Basics: Group B;
b -hemolytic; colonizes pharynx, GI, vagina; colonizes ~20% of pregnant women of which ~50% pass on to their child; Ag structure: 6 capsular serotypes
Infections
: sepsis and meningitis in neonates, puerperal infections in women, skin/peripheral infections, endocarditis
Therapy
: Group B remain susceptible to penicillin so they are therapy of choice
Viridans streptococci
Basics: diverse group,
a -hemolytic, micro-aerophilic (grow well in low oxygen conc)
Treatment
: viridan infection: penicillin; viridan native valve endocarditis: 4wk IV penicillin; if combine with streptomycin = 2wk
Species
: S. sanguis (endocarditis), S. mutans (dental plaque), S. anginorius (liver, brain absess), S. mitis (infection in neutropenic patients – lowered susceptibility to penicillin), S. salivarius, S. morbillorium
Group D streptococci
– Streptococcus bovis and Enterococcus
S. bovis
cause of endocarditis in community setting, associated with GI/colonic neoplasms (adenomas or carcinomas)
Intravenous penicillin therapy for 4 wks is treatment of choice
Enterococcus
now classified into own genus due to recent DNA homology studies; E. faecalis and E. faecium = human infect species
2nd most common cause of nosocomial infections (UTI and wound infections) and 3rd most common cause of bloodstream infections (native valve endocarditis specifically)
colonization: feces, mouth, urethra, perianal region, vagina; never goes away
has attained many anti-microbial resistances over the years therefore now a big problem in hospital infections
intrinsically
resistant to many commonly used anti-microbials (eg. cephalosporins)
tolerant
to the bactericidal activity of all cell wall active agents
acquired resistance
most recently to aminoglycoside and vancomycin (most worrisome)